Diabetes mellitus after stem cell transplantation in a patient with acute lymphoblastic leukemia: Possible association with tacrolimus

Pediatrics International

Volumn 49, Issue 4, 2007, Pages 530-532

  Niwa, Akira ^a   Matsubara, Hiroshi ^a   Adachi, Soichi ^a   Fujino, Hisanori ^a   Higashi, Yuri ^a   Umeda, Katsutsugu ^a   Shiota, Mitsutaka ^a   Hiramatsu, Hidefumi ^a   Kobayashi, Michihiro ^a   Watanabe, Ken Ichiro ^a   Yorifuji, Toru ^a   Nakahata, Tatsutoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Immunosuppressant; Post transplantation diabetes mellitus (PTDM); Prednisolone

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; INSULIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TACROLIMUS; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CONTINUOUS INFUSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; GLUCOSE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN TREATMENT; MALE; POSTTRANSPLANTATION DIABETES MELLITUS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; DIABETES MELLITUS, TYPE 2; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION; TACROLIMUS;

EID: 34250773379     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02418.x     Document Type: Article

References (10)

1. Kanekiyo T, Hara J, Matshubara-Hayashi Y et al. Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children. Int. J. Hematol. 2005 81 : 264 8.
2. Paolillo JA, Boyle GJ, Law YM et al. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. Transplantation 2001 81 : 252 5.
3. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidemia as late effects after bone-marrow transplantation in childhood. Lancet 2000 356 : 993 7.
4. Vialettes B, Maraninchi D, San Marco MP et al. Autoimmune polyendocrine failure-type 1 (insulin-dependent) diabetes mellitus and hypothyroidism-after allogeneic bone marrow transplantation in a patient with lymphoblastic leukemia. Diabetologia 1993 36 : 541 6.
5. Lampeter EF, McCann SR, Kolb H. Transfer of diabetes type 1 by bone-marrow transplantation. Lancet 1995 351 : 568 70.
6. Hirayama M, Azuma E, Kumamoto T et al. Late-onset unilateral renal dysfunction combined with non-insulin-dependent diabetes mellitus and bronchial asthma following allogeneic bone marrow transplantation for acute lymphoblastic leukemia in a child. Bone Marrow Transplant. 1998 22 : 923 6.
7. Schouten HC, Maragos D, Vose J, Armitage JO. Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation. Bone Marrow Transplant. 1990 6 : 333 5.
8. Maes BD, Kuypers D, Messiaen T et al. Posttransplantation diabetes mellitus in tacrolimus-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001 72 : 1655 61.
9. Weir MR, Fink JC. Risk for posttransplant mellitus with current immunosuppressive medications. Am. J. Kidney Dis. 1999 34 : 1 13.
10. Amin P, Shah S, Walker D, Page R. Adverse metabolic and cardiovascular risk following treatment of acute lymphoblastic leukemia in childhood; two case reports and a literature review. Diabet. Med. 2001 18 : 849 53.